Last Updated: 09/06/21
2021 Distribution of Grants
TRP currently uses the P50 (and the U54) funding mechanism for the SPORE program. In 2019, there were 54 funded SPOREs, covering 20 organ sites and systems, including one signaling pathway-focused grant. Fifty-three grants used the P50 mechanism, and the remaining grant was funded through a U54. In addition, TRP staff currently oversee a relatively smaller number of R21, R01, and R50 translational research grants.
Grants below include those that are receiving funding and those that are in no-cost extensions.
| Organ Site | 2021 |
|---|---|
| Bladder | 1 |
| Brain | 6 |
| Breast | 6 |
| Cervical | 1 |
| Endometrial | 1 |
| Epigenetics | 1 |
| Gastrointestinal | 5 |
| Head & Neck/Thyroid | 3 |
| Kidney | 2 |
| Leukemia | 4 |
| Liver | 2 |
| Lung | 5 |
| Lymphoma | 4 |
| Myeloma | 1 |
| Neuroendocrine | 1 |
| Ovarian | 5 |
| Pancreatic | 1 |
| Hyperactive RAS | 1 |
| Prostate | 7 |
| Sarcoma | 1 |
| Skin/Melanoma | 5 |
| TOTAL SPOREs | 63 |